| Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial BH Burmeister, BM Smithers, V Gebski, L Fitzgerald, RJ Simes, P Devitt, ... The lancet oncology 6 (9), 659-668, 2005 | 1172 | 2005 |
| Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial DP Dearnaley, MR Sydes, JD Graham, EG Aird, D Bottomley, RA Cowan, ... The lancet oncology 8 (6), 475-487, 2007 | 1100 | 2007 |
| Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results … P Grimm, I Billiet, D Bostwick, AP Dicker, S Frank, J Immerzeel, M Keyes, ... BJU international 109, 22-29, 2012 | 600 | 2012 |
| Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial DP Dearnaley, G Jovic, I Syndikus, V Khoo, RA Cowan, JD Graham, ... The lancet oncology 15 (4), 464-473, 2014 | 553 | 2014 |
| Activation of thymic regeneration in mice and humans following androgen blockade JS Sutherland, GL Goldberg, MV Hammett, AP Uldrich, SP Berzins, ... The Journal of Immunology 175 (4), 2741-2753, 2005 | 528 | 2005 |
| Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial A Kneebone, C Fraser-Browne, GM Duchesne, R Fisher, M Frydenberg, ... The Lancet Oncology 21 (10), 1331-1340, 2020 | 302 | 2020 |
| 15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience JE Sylvester, PD Grimm, JC Blasko, J Millar, PF Orio, S Skoglund, ... International Journal of Radiation Oncology* Biology* Physics 67 (1), 57-64, 2007 | 261 | 2007 |
| Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 … GM Duchesne, HH Woo, JK Bassett, SJ Bowe, C D'Este, M Frydenberg, ... The Lancet Oncology 17 (6), 727-737, 2016 | 243 | 2016 |
| Post-prostatectomy radiation therapy: consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-urinary group MA Sidhom, AB Kneebone, M Lehman, KL Wiltshire, JL Millar, ... Radiotherapy and Oncology 88 (1), 10-19, 2008 | 200 | 2008 |
| In vivo characterization and numerical simulation of prostate properties for non‐thermal irreversible electroporation ablation RE Neal, JL Millar, H Kavnoudias, P Royce, F Rosenfeldt, A Pham, ... The Prostate 74 (5), 458-468, 2014 | 141 | 2014 |
| Human immunodeficiency virus–related primary central nervous system lymphoma: Factors influencing survival in 111 patients ME Newell, JF Hoy, SG Cooper, B DeGraaff, AE Grulich, M Bryant, ... Cancer 100 (12), 2627-2636, 2004 | 141 | 2004 |
| AP hase III trial to investigate the timing of radiotherapy for prostate cancer with high‐risk features: background and rationale of the Radiotherapy–Adjuvant Versus Early … M Pearse, C Fraser‐Browne, ID Davis, GM Duchesne, R Fisher, ... BJU international 113, 7-12, 2014 | 133 | 2014 |
| Effect of aspirin on cancer incidence and mortality in older adults. JJ McNeil, P Gibbs, SG Orchard, JE Lockery, WB Bernstein, Y Cao, L Ford, ... J Natl Cancer Inst, 2020 | 129 | 2020 |
| Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011 SM Evans, JL Millar, ID Davis, DG Murphy, DM Bolton, GG Giles, ... Medical journal of Australia 198 (10), 540-545, 2013 | 104 | 2013 |
| The current use of active surveillance in an Australian cohort of men: a pattern of care analysis from the V ictorian Prostate Cancer Registry M Weerakoon, N Papa, N Lawrentschuk, S Evans, J Millar, M Frydenberg, ... BJU international 115, 50-56, 2015 | 103 | 2015 |
| Urethral strictures following high-dose-rate brachytherapy for prostate cancer: analysis of risk factors BR Hindson, JL Millar, B Matheson Brachytherapy 12 (1), 50-55, 2013 | 103 | 2013 |
| A randomized phase III trial of preoperative chemoradiation followed by surgery (CR-S) versus surgery alone (S) for localized respectable cancer of the esophagus BH Burmeister Prog Proc Am Soc Clin Oncol 21, 130a, 2002 | 94 | 2002 |
| High-dose-rate brachytherapy in combination with conformal external beam radiotherapy in the treatment of prostate cancer DR Zwahlen, N Andrianopoulos, B Matheson, GM Duchesne, JL Millar Brachytherapy 9 (1), 27-35, 2010 | 91 | 2010 |
| Effect of intensity-modulated pelvic radiotherapy on second cancer risk in the postoperative treatment of endometrial and cervical cancer DR Zwahlen, JD Ruben, P Jones, F Gagliardi, JL Millar, U Schneider International Journal of Radiation Oncology* Biology* Physics 74 (2), 539-545, 2009 | 86 | 2009 |
| The Prostate Cancer Registry: monitoring patterns and quality of care for men diagnosed with prostate cancer SM Evans, JL Millar, JM Wood, ID Davis, D Bolton, GG Giles, ... BJU international 111 (4b), E158-E166, 2013 | 81 | 2013 |
Susan EvansMonash UniversityPotvrđena adresa e-pošte na monash.edu